However, there was no effect on B-ALL development after Vps33b was specifically deleted in MSCs and MKs, as revealed by no changes in B-ALL cell frequency in the peripheral blood or overall survival in the recipient (Fig. 1e-1f and Fig. S1c-f). The gene discussed is VPS33B; the disease is precursor B-cell acute lymphoblastic leukemia.